Increased Spending on Specialty Drugs

A report released by the Blue Cross Blue Shield Association (the national federation of 36 independent, locally operated Blue Cross Blue Shield companies) found a 26 percent increase in spending per patient on specialty drugs between 2013 and 2014. Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.